D898_E901 <i>RET</i> Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms
Tommaso Porcelli(University of Naples Federico II), Domenico Salvatore(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy))
Cited by 5
Related Papers
DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
|The Journal of Clinical Endocrinology & Metabolism|2017|155
Activated Thyroid Hormone Promotes Differentiation and Chemotherapeutic Sensitization of Colorectal Cancer Stem Cells by Regulating Wnt and BMP4 Signaling
|Cancer Research|2015|78
Impact of a Cardio-Oncology Unit on Prevention of Cardiovascular Events in Cancer Patients
|ESC Heart Failure|2022|22